PS Ratio
N/A
14 min ago
Summary:
Cidara Therapeutics price to sales ratio is not available.CDTX PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CDTX PS Ratio Performance
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | - | +2.4% | +2.4% | - |
| 1 m1 month | - | +59.8% | +59.8% | - |
| 3 m3 months | - | +56.8% | +57.0% | - |
| 6 m6 months | - | +95.2% | +201.6% | - |
| ytdytd | - | +27.9% | +98.9% | - |
| 1 y1 year | - | +46.9% | +129.0% | - |
| 5 y5 years | - | -56.8% | +84.3% | - |
CDTX PS Ratio High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | ||||
| 3 m | 3 months | 1.49 | 1.21 | ||
| 6 m | 6 months | 1.56 | 0.72 | ||
| 1 y | 1 year | 1.60 | 0.69 | ||
| 3 y | 3 years | 2.73 | 0.54 | ||
| 5 y | 5 years | 14.06 | 0.54 | ||
| alltime | all time | 14.06 | 0.54 |
Cidara Therapeutics PS Ratio History
| Date | Value |
|---|---|
| 2023 | 0.86(+1.2%) |
| 2022 | 0.85(-51.1%) |
| Date | Value |
|---|---|
| 2021 | 1.74(-76.6%) |
| 2020 | 7.44(+19.8%) |
| 2019 | 6.21 |
FAQ
- What is the all time high PS ratio for Cidara Therapeutics?
What is the all time high PS ratio for Cidara Therapeutics?
Cidara Therapeutics all-time high price to sales ratio is 14.06